Prelude Capital Management’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-8,911
| Closed | -$442K | – | 1199 |
|
|
2023
Q3 | $442K | Buy |
+8,911
| New | +$498K | 0.03% | 511 |
|
|
2023
Q1 | – | Sell |
-8,321
| Closed | -$618K | – | 1295 |
|
|
2022
Q4 | $618K | Buy |
8,321
+853
| +11% | +$58.1K | 0.03% | 486 |
|
|
2022
Q3 | $445K | Sell |
7,468
-1,206
| -14% | -$72.6K | 0.02% | 695 |
|
|
2022
Q2 | $487K | Sell |
8,674
-5,205
| -38% | -$342K | 0.01% | 826 |
|
|
2022
Q1 | $1.02M | Buy |
+13,879
| New | +$965K | 0.03% | 571 |
|
|
2021
Q4 | – | Sell |
-8,348
| Closed | -$640K | – | 2078 |
|
|
2021
Q3 | $640K | Buy |
8,348
+5,111
| +158% | +$410K | 0.02% | 765 |
|
|
2021
Q2 | $251K | Sell |
3,237
-7,878
| -71% | -$560K | 0.01% | 1278 |
|
|
2021
Q1 | $685K | Sell |
11,115
-513
| -4% | -$32.5K | 0.02% | 762 |
|
|
2020
Q4 | $758K | Buy |
11,628
+9,202
| +379% | +$529K | 0.02% | 568 |
|
|
2020
Q3 | $120K | Buy |
2,426
+144
| +6% | +$7.43K | 0.01% | 848 |
|
|
2020
Q2 | $109K | Buy |
+2,282
| New | +$110K | 0.01% | 925 |
|
|
2019
Q2 | – | Sell |
-11,348
| Closed | -$561K | – | 1840 |
|
|
2019
Q1 | $561K | Buy |
11,348
+2,937
| +35% | +$133K | 0.03% | 466 |
|
|
2018
Q4 | $364K | Buy |
8,411
+1,798
| +27% | +$89.7K | 0.02% | 559 |
|
|
2018
Q3 | $375K | Buy |
6,613
+2,045
| +45% | +$108K | 0.02% | 607 |
|
|
2018
Q2 | $231K | Buy |
+4,568
| New | +$238K | 0.01% | 719 |
|
|
2017
Q3 | – | Sell |
-1,300
| Closed | -$43K | – | 1729 |
|
|
2017
Q2 | $43K | Sell |
1,300
-8,725
| -87% | -$274K | ﹤0.01% | 1050 |
|
|
2017
Q1 | $297K | Buy |
10,025
+9,425
| +1,571% | +$257K | 0.03% | 438 |
|
|
2016
Q4 | $15K | Sell |
600
-1,200
| -67% | -$27.3K | ﹤0.01% | 1338 |
|
|
2016
Q3 | $41K | Buy |
1,800
+1,500
| +500% | +$35.3K | ﹤0.01% | 1107 |
|
|
2016
Q2 | $7K | Buy |
+300
| New | +$7.2K | ﹤0.01% | 1425 |
|
|
2015
Q3 | – | Sell |
-700
| Closed | -$18K | – | 1591 |
|
|
2015
Q2 | $18K | Buy |
700
+98
| +16% | +$2.48K | ﹤0.01% | 1426 |
|
|
2015
Q1 | $15K | Sell |
602
-2,033
| -77% | -$49.5K | ﹤0.01% | 1787 |
|
|
2014
Q4 | $63K | Buy |
+2,635
| New | +$58.3K | 0.01% | 1174 |
|
|
2014
Q3 | – | Sell |
-1,850
| Closed | -$44K | – | 1944 |
|
|
2014
Q2 | $44K | Hold |
1,850
| – | – | 0.01% | 1410 |
|
|
2014
Q1 | $49K | Hold |
1,850
| – | – | 0.01% | 1313 |
|
|
2013
Q4 | $37K | Buy |
+1,850
| New | +$34.3K | 0.01% | 1150 |
|
Other funds holding GMED
CCM
Prelude Capital Management's GMED Position: Q4 2023 in Review
Prelude Capital Management sold out of Globus Medical (GMED) in Q4 2023, closing a stake of 8,911 shares — an estimated $442K sold.
Prelude Capital Management first reported a position in GMED in Q4 2013 and held it in 26 quarters. The position peaked at $1.02M in Q1 2022. 408 funds tracked by Wall St. Rank hold GMED as of Q4 2023.
- Prelude Capital Management reported no remaining Globus Medical position as of Q4 2023 after selling out during the quarter.
- Prelude Capital Management sold 8,911 Globus Medical shares in Q4 2023, an estimated $442K.
- Prelude Capital Management first reported a position in Globus Medical in Q4 2013 and held it in 26 quarters.
- Prelude Capital Management's Globus Medical position peaked at $1.02M in Q1 2022.
- 408 funds tracked by Wall St. Rank held Globus Medical as of Q4 2023.
Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.